The DOI matches its Crossref record; 113 of the 115 references it cites were found in a registry or an index.
Apolipoprotein E4 Potentiates Amyloid β Peptide-induced Lysosomal Leakage and Apoptosis in Neuronal Cells
Open accessAbstract
We assessed the isoform-specific effects of apolipoprotein (apo) E on the response of Neuro-2a cells to the amyloid beta peptide (Abeta1-42). As determined by the intracellular staining pattern and the release of beta-hexosaminidase into the cytosol, apoE4-transfected cells treated with aggregated Abeta1-42 showed a greater tendency toward lysosomal leakage than neo- or apoE3-transfected cells. Abeta1-42 caused significantly greater cell death and more than 2-fold greater DNA fragmentation in apoE4-secreting than in apoE3-secreting or control cells. H2O2 or staurosporine enhanced cell death and apoptosis in apoE4-transfected cells but not in apoE3-transfected cells. A caspase-9 inhibitor abolished the potentiation of Abeta1-42-induced apoptosis by apoE4. Similar results were obtained with conditioned medium from cells secreting apoE3 or apoE4. Cells preincubated for 4 h with a source of apoE3 or apoE4, followed by removal of apoE from the medium and from the cell surface, still exhibited the isoform-specific response to Abeta1-42, indicating that the potentiation of apoptosis required intracellular apoE, presumably in the endosomes or lysosomes. Studies of phospholipid (dimyristoylphosphatidylcholine) bilayer vesicles encapsulating 5-(and-6)-carboxyfluorescein dye showed that apoE4 remodeled and disrupted the phospholipid vesicles to a greater extent than apoE3 or apoE2. In response to Abeta1-42, vesicles containing apoE4 were disrupted to a greater extent than those containing apoE3. These findings are consistent with apoE4 forming a reactive molecular intermediate that avidly binds phospholipid and may insert into the lysosomal membrane, destabilizing it and causing lysosomal leakage and apoptosis in response to Abeta1-42.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Self-citationAssociation of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., & Yuan, J. (2000) · Nature · doi:10.1038/47513 · Cited by 3,292
Flagged first, then by citations
2 of the 115 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Slooter, 1997, J. Am. Med. Assoc., 277, 818, 10.1001/jama.1997.03540340052032 · DOI
- Wisniewski, 1994, Am. J. Pathol., 145, 1030
- Kaback, 1977, Prog. Clin. Biol. Res., 18, 267
- Morrow, 2000, Protein Sci., 9 Suppl. 1, 101
Cited by
Sorted by citations
Items 101–176 of 176
Du, J., Chang, J., Guo, S., Zhang, Q., & Wang, Z. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.07.032 · Cited by 40
A role for p53 in the β-amyloid-mediated regulation of the lysosomal system
Fogarty, M. P., McCormack, R. M., Noonan, J., Murphy, D. B., Gowran, A., & Campbell, V. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.018 · Cited by 35
The Role of Upregulated APOE in Alzheimer's Disease Etiology
Gottschalk, W. K., & Mihovilovic, M. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000209 · Cited by 33
Giarratana, A. O., Zheng, C., Reddi, S., Teng, S. L., Berger, D. S., Adler, D., Sullivan, P. M., Thakker‐Varia, S., & Alder, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-76849-x · Cited by 39
APOE Genotype and Functional Outcome Following Aneurysmal Subarachnoid Hemorrhage
Gallek, M. J., Conley, Y. P., Sherwood, P. R., Horowitz, M. B., Kassam, A. B., & Alexander, S. A. (2008) · Biological Research For Nursing · doi:10.1177/1099800408323221 · Cited by 33
Human APOE genotype affects intraneuronal A 1-42 accumulation in a lentiviral gene transfer model
Zhao, W., Dumanis, S. B., Tamboli, I. Y., Rodriguez, G. A., Jo LaDu, M., Moussa, C. E. H., & William Rebeck, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt525 · Cited by 32
Preman, P., Moechars, D., Fertan, E., Wolfs, L., Serneels, L., Shah, D., Lamote, J., Poovathingal, S., Snellinx, A., Mancuso, R., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00162-7 · Cited by 32
Bartels, K., Li, Y., Li, Y.-W., White, W. D., Laskowitz, D. T., Kertai, M. D., Stafford‐Smith, M., Podgoreanu, M. V., Newman, M. F., & Mathew, J. P. (2015) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-015-0337-8 · Cited by 29
Membrane channel hypothesis of lysosomal permeabilization by beta-amyloid
Zaretsky, D. V., Zaretskaia, M. V., & Molkov, Y. I. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136338 · Cited by 28
Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer’s disease
Zaretsky, D. V., & Zaretskaia, M. V. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135959 · Cited by 27
Endosomal Acid-Base Homeostasis in Neurodegenerative Diseases
Prasad, H., & Rao, R. (2020) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2020_25 · Cited by 25
Acevedo, S. F., McGinnis, G. J., & Raber, J. (2008) · Radiation Research · doi:10.1667/rr1494.1 · Cited by 25
Hellén, M., Weert, I., Müller, S. A., Räsänen, N., Kettunen, P., Lehtonen, Š., Peitz, M., Fließbach, K., Takalo, M., Koskuvi, M., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03470-y · Cited by 25
Lysosomal proteomics reveals mechanisms of neuronal APOE4-associated lysosomal dysfunction
Krogsaeter, E., McKetney, J., Valiente‐Banuet, L., Marquez, A., Willis, A., Cakir, Z., Stevenson, E. J., Jang, G. Μ., Rao, A. T., Li, E., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2576613 · Cited by 22
Self-citationDu, M., Yu, Y., Wang, J., & Ji, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010366 · Cited by 22
Patients with Alzheimer’s disease have an increased removal rate of soluble beta-amyloid-42
Zaretsky, D. V., Zaretskaia, M. V., Molkov, Y. I., & Initiative, A. D. N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276933 · Cited by 25
Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins
Ułamek-Kozioł, M., Pluta, R. M., Bogucka‐Kocka, A., Januszewski, S., Kocki, J., & Czuczwar, S. J. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.01.006 · Cited by 19
Ruiz-Arlandis, G., Pieri, L., Bousset, L., & Melki, R. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12258 · Cited by 21
A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
Chen, H., Chen, F., Jiang, Y., Zhang, L., Hu, G., Sun, F., Zhang, M., Ji, Y., Chen, Y., Che, G., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.881239 · Cited by 19
Cerebrospinal Fluid Proteins as Regulators of Beta‐amyloid Aggregation and Toxicity
Pate, K. M., & Murphy, R. M. (2017) · Israel Journal of Chemistry · doi:10.1002/ijch.201600078 · Cited by 17
Alzheimer’s disease basics: we all should know
Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 19
Iurescia, S., Fioretti, D. P., Mangialasche, F., & Rinaldi, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100009 · Cited by 18
Lazo, N. D., Maji, S. K., Fradinger, E. A., Bitan, G., & Teplow, D. B. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch17 · Cited by 18
Huang, Z., Maeda, N., & Mazzone, T. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m017160 · Cited by 16
A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer’s Disease
Chen, H., Chen, F., Zhang, M., Chen, Y., Cui, L., & Liang, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210602 · Cited by 15
Belinson, H., & Michaelson, D. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1065 · Cited by 15
CSF cutoffs for MCI due to AD depend on APOEε4 carrier status
Marizzoni, M., Ferrari, C., Babiloni, C., Albani, D., Barkhof, F., Cavaliere, L., Didic, M., Forloni, G., Fusco, F., Galluzzi, S., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.019 · Cited by 15
Min, L., Iwanami, J., Shudou, M., Bai, H., Shan, B., Higaki, A., Mogi, M., & Horiuchi, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01775-8 · Cited by 15
Waldie, S., Sebastiani, F., Moulin, M., Giudice, R. D., Paracini, N., Roosen-Runge, F., Gerelli, Y., Prévost, S., Voss, J., Darwish, T., et al. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.630152 · Cited by 9
Age-related lysosomal dysfunction: an unrecognized roadblock for cobalamin trafficking?
Zhao, H., Brunk, U. T., & Garner, B. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0861-9 · Cited by 13
Alzheimer's Factors in Ischemic Brain Injury
Pluta, R. M., & Jaboski, M. (2012) · InTech eBooks · doi:10.5772/27205 · Cited by 9
Endocytic mechanisms and drug discovery in neurodegenerative diseases
Zhang, M. (2008) · Frontiers in bioscience · doi:10.2741/3140 · Cited by 8
Samy, A. S., & Igwe, O. J. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9670-8 · Cited by 8
Li, C., Fang, C., Cabrerizo, M., Barreto, A. B., Andrian, J. H., Duara, R., Loewenstein, D., & Adjouadi, M. (2017) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2017.8217994 · Cited by 8
S, H. S. G. N., Rajalekshmi, S. G., Murahari, M., & Burri, R. R. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1671231 · Cited by 8
Zaretsky, D. V., & Zaretskaia, M. V. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119145 · Cited by 8
Frisardi, V. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111568 · Cited by 7
Tong, J., Lang, J., & Zhu, L. (2010) · International Urogynecology Journal · doi:10.1007/s00192-010-1222-1 · Cited by 7
Zuniga, N. R., Earls, N. E., Denos, A. E. A., Elison, J. M., Jones, B. S., Smith, E. G., Moran, N. G., Broce, K. L., Romero, G. M., Hyer, C. D., et al. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012407 · Cited by 9
Mo, Y., Liu, H., Keszei, A. F. A., Dai, D. L., Makky, A., Ding, L., Pan, A., Bu, J., Mazhab‐Jafari, M. T., Chen, J., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c16025 · Cited by 6
Oxidative Stress in Neurodegenerative Diseases
Alami, M., Fülöp, T., Boumezough, K., Khalil, A., Zerif, E., & Berrougui, H. (2024) · Springer eBooks · doi:10.1007/978-3-031-69962-7_4 · Cited by 6
Molkov, Y. I., Zaretskaia, M. V., Zaretsky, D. V., & Initiative, T. A. D. N. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230821141745 · Cited by 4
Ługowska, A., Musielak, M., Jamroz, E., Pyrkosz, A., Kmieć, T., Tylki‐Szymańska, A., & Bednarska‐Makaruk, M. (2013) · Gene · doi:10.1016/j.gene.2013.05.009 · Cited by 4
Köse, S., Çınar, E., Akyel, H., Cakir-Aktas, C., Tel, B. C., Karataş, H., & Kelicen‐Uğur, P. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123105 · Cited by 3
Alzheimer’s Disease: From Pathogenesis to Emerging Therapeutic Targets
Takahashi, T., & Muguruma, K. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062357 · Cited by 3
Kimura, A., Hata, S., & Suzuki, T. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.07.017 · Cited by 3
Wolfe, D. M., & Nixon, R. A. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814350457_0010 · Cited by 3
Genomic and proteomic conversion of brain ischemia to Alzheimer’s disease
Pluta, R. M., & Ułamek-Kozioł, M. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1804251 · Cited by 3
The Framework for an Integrative Theory of Alzheimer’s Disease
Zaretsky, D. V., & Zaretskaia, M. V. (2025) · Current Alzheimer Research · doi:10.2174/0115672050381553250425062803 · Cited by 2
Amyloid fibrils are nanoparticles that target lysosomes.
Jakhria, T. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University) · Cited by 2
Perturbed Brain Energy Metabolism in Alzheimer’s Disease and Diabetes
Wu, L. (2017) · KU ScholarWorks (University of Kansas) · Cited by 2
Protective mutations associated with APOE in Alzheimer’s disease
Ma, Y., Li, Y., Wu, G., Liu, L., Tian, M., Han, X., Chen, X., Xuan, X., Zheng, T., Gao, X., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03496-5 · Cited by 1
Genetic Risk Factors: Their Function and Comorbidities in Alzheimer′s Disease
Hiltunen, M. O., Bertram, L., & Saunders, A. J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/925362 · Cited by 1
Bansal, V. A., Tan, J. M., Soon, H. R., Zainolabidin, N., Saido, T. C., & Ch’ng, T. H. (2024) · eLife · doi:10.7554/elife.92069.3 · Cited by 4
Can Microbes Play a Role in the Pathogenesis of Alzheimer Disease?
Fong, I. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1670-2_7 · Cited by 1
ApoE and Alzheimer's disease--10 years later.
Mariani, S. M. (2004) · PubMed Central · Cited by 1
Metabolic Abnormalities in Alzheimer Disease
Gebhardt, F. M., & Dodd, P. R. (2008) · Springer eBooks · doi:10.1007/978-0-387-79112-8_22 · Cited by 1
Patients with Alzheimer’s disease have increased cellular amyloid uptakePreprint
Zaretsky, D. V., Zaretskaia, M. V., Molkov, Y. I., & Initiative, A. D. N. (2022) · medRxiv · doi:10.1101/2022.01.12.22269196 · Cited by 1
Delano‐Wood, L. (2011) · Defense Technical Information Center (DTIC) · doi:10.21236/ada560750
Acidic vesicles of the endo-exocytic pathways as targets for some anti-monoamine oxidase drugs
Dell’Antone, P., IbnLkayat, M., Drago, D., & Zatta, P. F. (2007) · Metabolic Brain Disease · doi:10.1007/s11011-007-9054-5
Original Article Amyloid-beta alters trafficking of internalized acetylcholinesterase and dextran
Hu, W. T., Gray, N. W., Brimijoin, S., & Mn, R. (2009)
The Rho GTPases Rac1, Cdc42, and RhoA Regulate APP Transport to Lysosomes and Aβ Production
Chiu, & Justin, K. (2015) · Scholarship@Western (Western University)
Albrecht, M. A., & Foster, J. K. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_7
Hawley, B. (2012) · uO Research (University of Ottawa) · doi:10.20381/ruor-6225
Pathogenesis of Alzheimer Disease: Metabolic Factors
(2004) · Springer eBooks · doi:10.1007/0-306-48529-x_15
Bansal, V. A., Tan, J. M., Soon, H. R., Zainolabidin, N., Saito, T., & Ch’ng, T. H. (2024) · eLife · doi:10.7554/elife.92069.1
Bansal, V. A., Tan, J. M., Soon, H. R., Zainolabidin, N., Saito, T., & Ch’ng, T. H. (2024) · eLife · doi:10.7554/elife.92069.2
Hellén, M., Weert, I., Müller, S. A., Lehtonen, Š., Peitz, M., Fließbach, K., Takalo, M., Koskuvi, M., Lichtenthaler, S. F., Leinonen, V., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6241569/v1
Özkurt, Ç., Köse, S., Karasu, Ç., Kortholt, A., & Kelicen‐Uğur, P. (2025) · Research Square · doi:10.21203/rs.3.rs-7094261/v1
Min, L.-J., Iwanami, J., Shudou, M., Bai, H.-Y., Shan, B.-S., Higaki, A., Mogi, M., & Horiuchi, M. (2020) · Figshare · doi:10.6084/m9.figshare.12097464
Sepulveda-Diaz, J. E. (2013) · theses.fr (ABES) · doi:10.70675/56c42bcbz41dfz432bzbb78z77110b373285
Binding and internalization of exogenous protein assemblies by mammalian cells
Ruiz-Arlandis, G. (2015) · theses.fr (ABES) · doi:10.70675/437e0532ze4e1z4966z80e5z340b6fd3c49d
Özkurt, Ç., Köse, S., Karasu, Ç., Kortholt, A., & Kelicen‐Uğur, P. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04792-w
Frosina, M., Maurotti, S., Castagna, A., Montalcini, T., Pujia, A., & Tirinato, L. (2026) · MedComm · doi:10.1002/mco2.70789
Mechanisms of autophagy–lysosome pathway impairment in Alzheimer's disease
Lü, K., Lu, Y., Tang, R., Dong, X., Zhuang, P., Gao, Y., Cheng, M., Wang, Y., & Wang, Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261460879
Autophagy-lysosomal pathway in neurodegeneration
McDonough, S. R., Rao, A. K., McAleer, J. M., Babrowicz, B. M., & Sharma, M. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00041-0
Metadata
- Authors
- Ji, Z.-S., Miranda, R. D., Newhouse, Y. M., Weisgraber, K. H., Huang, Y., & Mahley, R. W.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Mahley, Robert W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 277
- Issue
- 24
- Pages
- 21821-21828
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2043090568
- Cited by
- 177
- References
- 115
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 9 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 8 · 2019: 6 · 2018: 3 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 4 · 2013: 6 · 2012: 11
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01hl047660-10)
- National Heart, Lung, and Blood Institute (HL-47660)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- APOE ε4, apolipoprotein E isoforms, amyloid-beta, amyloid-beta 42, apoptosis, N2a cells, caspase-9, DNA fragmentation, lysosomal membrane destabilization, endosomes, Alzheimer's disease
- MeSH terms
- Animals, Apolipoproteins E, Dimyristoylphosphatidylcholine, Enzyme Inhibitors, Humans, Hydrogen Peroxide, Lysosomes, Microscopy, Fluorescence, Neurons, Time Factors, Transfection, Tumor Cells, Cultured, Amyloid beta-Peptides, Apoptosis, Staurosporine, Protein Isoforms, Mice, Apolipoprotein E4, DNA Fragmentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
